TRIM22 and glioblastoma: The increases in the growth of GBM cells (Fig. 6b, Supplementary Fig. 8b) and positive expression rate of Ki67 (Fig. 6c, Supplementary Fig. 8c) induced by TRIM22 overexpression were also attenuated by Raf-1S338A.